Related Experiment Video
Updated: May 15, 2025

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Injectable Contraceptives Differentially Affect Select CD4+ HIV-1 Target Cells in the Genital Tract but Not
Chanel Avenant1, Alexis J Bick1, Johnson M Moliki1
1Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.
Problem:
Observational data suggest lower HIV susceptibility in women using the injectable contraceptive norethisterone enanthate (NET-EN) versus intramuscular depo medroxyprogesterone acetate (DMPA-IM). Clinical data investigating the effects of injectables on HIV target cells are inconsistent or limited. No data on HIV target cells are available from head-to-head randomized trials comparing DMPA-IM and NET-EN, nor at peak progestin concentrations.
Method Of Study:
The women's health, injectable contraception, and HIV (WHICH) trial randomized women to DMPA-IM or NET-EN at two South African sites (2018-2019). Cells from blood and cytobrushes from women at one site, taken at baseline and 1 week post the 24-week injection (at peak progestin levels), were analyzed by flow cytometry for select HIV-1 target cells (CD4+ cells expressing HIV-1 co-receptors, an integrin and/or activation markers).
Results:
Systemically, DMPA-IM and NET-EN similarly reduced the frequency and number of some CD4+ cells and expression of some CD4+ cell surface markers. In contrast, female genital tract (FGT) results showed significantly different cell numbers between contraceptives for most cell populations; DMPA-IM tended to increase, but NET-EN tended to decrease cell numbers. Excluding for non-study progestin use revealed significant increases in frequency and/or number of several FGT cell populations from baseline to 25 weeks, within the DMPA-IM arm.
Conclusions:
Both contraceptives exert minimal effects on systemic CD4+ cells but have differential effects in the FGT. The changes in frequency and numbers of HIV-1 target cells investigated, particularly after exclusion for non-study progestin use, suggest that DMPA-IM use may increase HIV-1 acquisition in the FGT compared to NET-EN use.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

